Computed tomography is more sensitive than CA 125 in detecting disease
progression in patients with platinum-resistant ovarian cancer: Analysis
of the AURELIA trial
Computed tomography is more sensitive than CA 125 in detecting disease progression in patients with platinum-resistant ovarian cancer: Analysis of the AURELIA trial
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2015
Συγγραφείς:
Lindeman, K. Kristensen, G. Mirza, M. Raza Davies, L. and Hilpert, F. Romero, I. Ayhan, A. Burges, A. Rubio, M. J. and Raspagliesi, F. Huizing, M. Creemers, G. J. Lykka, M. and Lee, C. Gebski, V. Lauraine, E. Pujade
